Evidence map›Paper›PMID 36475650›Full record

ArticleJournal of the American Chemical Society2022

Middle-Down Mass Spectrometry Reveals Activity-Modifying Phosphorylation Barcode in a Class C G Protein-Coupled Receptor.

Ashley N Ives, Henry A Dunn, Hamid Samareh Afsari, Henrique Dos Santos Seckler, Max J Foroutan, Erica Chavez, Rafael D Melani, Ryan T Fellers, Richard D LeDuc, Paul M Thomas and 3 more

Open access · greenAbstract read
In one paragraph

Article in Journal of the American Chemical Society, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 17 citations in OpenAlex.

  1. Uncovering the covalent inhibitors of SARS-CoV-2 MJournal of pharmaceutical analysis · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 2 countries.

Ashley N IvesDepartment of Chemistry, Northwestern University, Evanston, Illinois 60208 United States.ORCID 0000-0002-1318-5732
Henry A DunnDepartment of Neuroscience, The Scripps Research Institute, Jupiter, Florida 33458, United States.
Hamid Samareh AfsariDepartment of Molecular Biosciences, Northwestern University, Evanston, Illinois 60208, United States.ORCID 0000-0002-5839-4765
Henrique Dos Santos SecklerDepartment of Chemistry, Northwestern University, Evanston, Illinois 60208 United States.
Max J ForoutanDepartment of Molecular Biosciences, Northwestern University, Evanston, Illinois 60208, United States.
Erica ChavezDepartment of Molecular Biosciences, Northwestern University, Evanston, Illinois 60208, United States.
Rafael D MelaniDepartment of Molecular Biosciences, Northwestern University, Evanston, Illinois 60208, United States.
Ryan T FellersNational Resource for Translational and Developmental Proteomics, Northwestern University, Evanston, Illinois 60208, United States.
Richard D LeDucNational Resource for Translational and Developmental Proteomics, Northwestern University, Evanston, Illinois 60208, United States.ORCID 0000-0002-6951-2923
Paul M ThomasDepartment of Molecular Biosciences, Northwestern University, Evanston, Illinois 60208, United States.
Kirill A MartemyanovDepartment of Neuroscience, The Scripps Research Institute, Jupiter, Florida 33458, United States.
Neil L KelleherDepartment of Chemistry, Northwestern University, Evanston, Illinois 60208 United States.ORCID 0000-0002-8815-3372
Reza VafabakhshDepartment of Molecular Biosciences, Northwestern University, Evanston, Illinois 60208, United States.ORCID 0000-0001-8384-3203
Northwestern University · USScripps Research Institute · US

Funding

Tumor Environment and Metastasis (TEAM) Research ProgramP30CA060553 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI LEONIDAS C. PLATANIAS · 1993 to 2026
$153.9M
TR&D 7: Cell Specific ProteomicsP41GM108569 · NIGMS · NORTHWESTERN UNIVERSITY · PI KELLEHER, NEIL L · 2015 to 2024
$13.6M
Orphan Receptors in Regulation of Neuronal G Protein SignalingR01MH105482 · NIMH · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI Kirill A. Martemyanov · 2015 to 2026
$6.1M
Defining native proteoform landscape for amyloid-beta in Alzheimers diseaseRF1AG063903 · NIA · NORTHWESTERN UNIVERSITY · PI KELLEHER, NEIL L, KLEIN, WILLIAM L · 2019 to 2019
$2.9M
Chemistry of Life Processes Predoctoral Training ProgramT32GM105538 · NIGMS · NORTHWESTERN UNIVERSITY · PI KELLEHER, NEIL L · 2013 to 2022
$2.7M
Quantitative analysis of metabotropic glutamate receptor activation and modulationR01GM140272 · NIGMS · NORTHWESTERN UNIVERSITY · PI VAFABAKHSH, REZA · 2020 to 2024
$1.7M
5-laser 30-parameter FACSymphony-S6 SORP Cell Sorter from BD BiosciencesS10OD026814 · OD · NORTHWESTERN UNIVERSITY AT CHICAGO · PI PERLMAN, HARRIS R · 2019 to 2019
$904k
FACSAria SORP Cell SorterS10OD011996 · OD · NORTHWESTERN UNIVERSITY AT CHICAGO · PI GOOLSBY, CHARLES L. · 2012 to 2012
$482k
Characterizing phosphorylation-dependent regulation of metabotropic glutamate receptors by middle-down mass spectrometryF31MH129114 · NIMH · NORTHWESTERN UNIVERSITY · PI IVES, ASHLEY NICHOLE · 2022 to 2023
$75k
NCI NIH HHS P30 CA060553NIA NIH HHS RF1 AG063903NIGMS NIH HHS P41 GM108569NIGMS NIH HHS R01 GM140272NIGMS NIH HHS T32 GM105538NIH HHS S10 OD011996NIH HHS S10 OD026814NIMH NIH HHS F31 MH129114NIMH NIH HHS R01 MH105482
6 · The paper itself

Abstract

G protein-coupled receptors (GPCRs) are the largest family of membrane receptors in humans. They mediate nearly all aspects of human physiology and thus are of high therapeutic interest. GPCR signaling is regulated in space and time by receptor phosphorylation. It is believed that different phosphorylation states are possible for a single receptor, and each encodes for unique signaling outcomes. Methods to determine the phosphorylation status of GPCRs are critical for understanding receptor physiology and signaling properties of GPCR ligands and therapeutics. However, common proteomic techniques have provided limited quantitative information regarding total receptor phosphorylation stoichiometry, relative abundances of isomeric modification states, and temporal dynamics of these parameters. Here, we report a novel middle-down proteomic strategy and parallel reaction monitoring (PRM) to quantify the phosphorylation states of the C-terminal tail of metabotropic glutamate receptor 2 (mGluR2). By this approach, we found that mGluR2 is subject to both basal and agonist-induced phosphorylation at up to four simultaneous sites with varying probability. Using a PRM tandem mass spectrometry methodology, we localized the positions and quantified the relative abundance of phosphorylations following treatment with an agonist. Our analysis showed that phosphorylation within specific regions of the C-terminal tail of mGluR2 is sensitive to receptor activation, and subsequent site-directed mutagenesis of these sites identified key regions which tune receptor sensitivity. This study demonstrates that middle-down purification followed by label-free quantification is a powerful, quantitative, and accessible tool for characterizing phosphorylation states of GPCRs and other challenging proteins.

Indexed as

Receptors, G-Protein-CoupledSignal TransductionCarrier ProteinsHumansLigandsMass SpectrometryPhosphorylationProteomicsCarrier ProteinsLigandsReceptors, G-Protein-Coupled

Identifiers

PMID36475650
PMCPMC9785046
OpenAlexW4313214255

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.